Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Kidney Neoplasms × Etoposide × Clear all

Phase

Status

Completed 3 Unknown 2 Withdrawn 1 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Small Cell Lung Carcinoma 20 Lymphoma, Large B-Cell, Diffuse 9 Lung Neoplasms 7 Burkitt Lymphoma 7 Lymphoma, Non-Hodgkin 6 Lymphoma, B-Cell 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Lymphoma 5 Hodgkin Disease 5 Neoplasms, Germ Cell and Embryonal 4 Medulloblastoma 4 Leukemia, Myeloid, Acute 4 Small Cell Lung Cancer Extensive Stage 3 Neuroblastoma 3 Multiple Myeloma 3 Carcinoma, Neuroendocrine 3 Brain Neoplasms 3 Wilms Tumor 2 Urinary Bladder Neoplasms 2 Teratoma 2 Seminoma 2 SCLC,Extensive Stage 2 Retinoblastoma 2 Recurrence 2 Plasmablastic Lymphoma 2 Hematologic Neoplasms 2 Glioma 2 Glioblastoma 2 Extensive Stage Small Cell Lung Cancer 2 Ependymoma 2

Interventions

cabozantinib 7 pembrolizumab 5 Nivolumab 5 Radiosurgery 3 Ipilimumab 3 Blood Specimen Collection 3 Axitinib 3 lenvatinib 2 Radiotherapy 2 Biopsy 2 zimberelimab 1 tislelizumab 1 polyethylene glycol 3350 1 pazopanib 1 olaparib 1 gallium Ga 68 dotatate 1 brodalumab 1 belzutifan 1 anlotinib 1 adagrasib 1 Watchful Waiting 1 Vincristine 1 Ultrasonography 1 Temozolomide 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sunitinib 1 Standard of Care 1 Radionuclide Imaging 1 Radiofrequency Ablation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05384821 2026-03-18

MetroWilms

Centre Oscar Lambret

Phase 1/2 Recruiting

Kidney Neoplasms, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡